Progress towards identifying biomarkers of vascular aging for total cardiovascular risk prediction

Charalambos Vlachopoulos1

  • 1Peripheral Vessels Unit, 1st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece. cvlachop@otenet.gr

Journal of Hypertension
|November 6, 2012
PubMed

Insights

Vascular aging biomarkers, like arterial stiffness, show promise for predicting cardiovascular risk beyond traditional factors. Arterial stiffness meets clinical criteria, while endothelial function has limitations for risk prediction.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Vascular Biology

Background:

  • Traditional cardiovascular risk scores have limitations in predicting actual events.
  • Vascular aging, reflecting cumulative risk factor impact on arteries, offers a potential measure of overall cardiovascular risk.
  • Integrating new biomarkers requires validation for calibration, discrimination, and reclassification.

Purpose of the Study:

  • To evaluate candidate arterial biomarkers for their potential to gauge cardiovascular risk.
  • To assess if arterial biomarkers provide incremental predictive value over traditional risk factors.
  • To determine which arterial biomarkers meet stringent criteria for clinical practice integration.

Main Methods:

  • Review of current evidence on arterial stiffness, central hemodynamics, carotid intima-media thickness, and endothelial function.
  • Assessment of biomarkers against criteria for calibration, discrimination, and reclassification.
  • Comparison of predictive value against established cardiovascular risk factors.

Main Results:

  • Arterial stiffness demonstrates fulfillment of criteria for a vascular aging biomarker.
  • Central hemodynamics and carotid intima-media thickness are considered close contenders.
  • Endothelial function exhibits methodological limitations impacting its risk prediction utility.

Conclusions:

  • Arterial stiffness is a validated biomarker for vascular aging and cardiovascular risk assessment.
  • Central hemodynamics and carotid intima-media thickness warrant further investigation for clinical application.
  • Endothelial function, due to methodological variability, is less suitable for routine cardiovascular risk prediction.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...